$0.784800
-0.09-10.67%
Last update: 3:17 PM
15 minutes delayed
NeuroSense Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NeuroSense Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
NRSN | NeuroSense Therapeutics | -$0.44 | -$0.20 | — | — | $0.00 | — | — | — | 08/14/2024 | Get Alert |
NRSN | NeuroSense Therapeutics | -$0.33 | -$0.20 | -$0.35 | -75.00% | $0.00 | — | $0.00 | — | 06/24/2024 | Get Alert |
NRSN | NeuroSense Therapeutics | -$0.27 | -$0.23 | -$0.16 | 30.43% | $0.00 | — | $0.00 | — | 04/05/2024 | Get Alert |
NRSN | NeuroSense Therapeutics | -$0.25 | — | $0.10 | — | $0.00 | — | $0.00 | — | 11/28/2023 | Get Alert |
NRSN | NeuroSense Therapeutics | -$0.31 | — | -$0.44 | — | $0.00 | — | $0.00 | — | 08/16/2023 | Get Alert |
NRSN | NeuroSense Therapeutics | -$0.24 | — | -$0.33 | — | $0.00 | — | $0.00 | — | 06/01/2023 | Get Alert |
NRSN | NeuroSense Therapeutics | — | — | -$0.27 | — | — | — | $0.00 | — | 03/22/2023 | Get Alert |
NRSN | NeuroSense Therapeutics | $0.93 | — | -$0.25 | — | $0.00 | — | $0.00 | — | 12/01/2022 | Get Alert |
NRSN | NeuroSense Therapeutics | -$1.24 | — | -$0.31 | — | $0.00 | — | $0.00 | — | 08/31/2022 | Get Alert |
NRSN | NeuroSense Therapeutics | -$0.38 | — | -$0.24 | — | $0.00 | — | $0.00 | — | 05/31/2022 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-06-24 | $-0.35 | $-0.20 | -75.0 % |
Mar 2024 | 2024-04-05 | $-0.16 | $-0.23 | 30.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
NeuroSense Therapeutics (NRSN) is scheduled to report earnings on August 14, 2024. The last reported earnings were for reported on June 24, 2024 for Q1.
The Actual EPS was $-0.35, which missed the estimate of $-0.20.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.